Joel Greenblatt Macrogenics Inc Transaction History

Gotham Asset Management, LLC

  • $9.41 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$20.49 - $35.63 $212,010 - $368,663
-10,347 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$18.99 - $33.2 $196,489 - $343,520
10,347 New
10,347 $330,000
Q2 2018

Aug 14, 2018
SELL
$19.78 - $24.67 $205,890 - $256,790
-10,409 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$18.89 - $32.46 $196,626 - $337,876
10,409 New
10,409 $262,000

Others Institutions Holding MGNX

# of Institutions
132
Shares Held
55.4M
Call Options Held
215K
Put Options Held
238K
View Full List

About MACROGENICS INC

MGNX Quotes by TradingView
  • Ticker MGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,458,800
  • Market Cap $199M
  • Description
  • MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...
More about MGNX
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email